Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Recurrent Pregnancy Loss -

Recurrent Pregnancy Loss

Causes, Controversies and Treatment

Howard Carp (Herausgeber)

Buch | Hardcover
300 Seiten
2020 | 3rd edition
CRC Press (Verlag)
978-1-138-32565-4 (ISBN)
CHF 296,75 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Recurrent pregnancy loss presents a vexing clinical problem in both reproductive medicine and maternal-fetal medicine. Exploring basic science and clinical applications, the third edition of this bestselling text provides an authoritative and comprehensive update on advances in the understanding and management of this troubling phenomenon.
Major advances in genetics, immunology, and endocrinology have necessitated a new edition of this best-selling text. However, despite the advances, recurrent pregnancy loss presents a frustrating clinical problem. There is still disagreement about the number of pregnancy losses which warrant investigation and treatment and about which investigations should be performed.

This third edition provides an authoritative and comprehensive update on advances in the understanding and management of this troubling phenomenon, covering both basic scientific topics such as genetics and cytokines, and profiles major advances in immunology, endocrinology, and thrombotic mechanism. Clinical research is discussed, as is assessment of results when applying an evidence-based approach or a more personalised approach, which is now becoming possible due to advances in the diagnosis of cause. There are lively debates on the role of progestogens and immunotherapy, which remain controversial.

Designed for specialists working in reproductive medicine clinics and those involved with maternal-fetal care, the book is also ideal for generalists and gynecologists seeking a comprehensive view of developments in the field.

Howard J.A. Carp, MB BS, FRCOG, is Clinical Professor, Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Part I: Basic Principles. 1.The Epidemiology of Recurrent Pregnancy Loss. 2. The Signaling between Embryo and Mother as a Basis for the Development of Tolerance. 3. Recurrent Pregnancy Loss: From Evidence-Based to Personalized Medicine. Part II: Etiology. 4. The Genetics of Spontaneous Abortions. 5. The Endometrial Factor in Recurrent Pregnancy Loss. 6. Fetal Structural Malformations and Recurrent Pregnancy Loss. 7. The Endocrinology of Recurrent Pregnancy Loss. 8. The Etiology of the Antiphospholipid Syndrome. 9. Defects in Coagulation Factors Leading to Recurrent Pregnancy Loss. 10. The Immunobiology of Recurrent Mmiscarriage. 11. Immune Testing in Recurrent Pregnancy Loss. 12. Uterine Anomalies and Recurrent Pregnancy Loss. 13. The Male Factor in Recurrent Pregnancy Loss. Part III: The Developing Pregnancy. 14. Ultrasound Follow-Up in Early Pregnancy. 15. Threatened Miscarriage and Recurrent Pregnancy Loss. 16. The Role of Cerclage and Pessaries. 17. What Genetic Screening Is Appropriate in Recurrent Pregnancy Loss? 18. Obstetric Outcomes after Recurrent Pregnancy Loss. Part IV: Management. 19. Investigation Protocol for Recurrent Pregnancy Loss. 20. Debate: Should Progestogens Be Used in Recurrent Pregnancy Loss? Yes. 21. Debate: Should Progestogens Be Used in Recurrent Pregnancy Loss? No. 22. Human Chorionic Gonadotropin Supplementation in Recurrent Pregnancy Loss. 23. Antiphospholipid Syndrome: Management of the Obstetric Patient. 24. Can Recurrent Pregnancy Loss Be Prevented by Antithrombotic Agents? 25. Empirical In Vitro Fertilization for Recurrent Pregnancy Loss: Is It a Valid Concept? 26. Debate: Should PGT-A Still Be Performed in Recurrent Pregnancy Loss? Yes. 27.Debate: Should PGT-A Still Be Performed in Recurrent Pregnancy Loss? No. 28. Third Party Reproduction in Recurrent Pregnancy Loss. Part V: Immunotherapy. 29. Leucocyte Immunotherapy for Recurrent Miscarriage. 30. IVIg Treatment for Recurrent Pregnancy Loss. 31. The Role of Filgrastrim. 32. Opinion: Immunotherapy Has No Place in the Treatment of Recurrent Pregnancy Loss.

Erscheinungsdatum
Reihe/Serie Series in Maternal-Fetal Medicine
Zusatzinfo 32 Tables, black and white; 22 Line drawings, black and white; 36 Halftones, black and white; 58 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 178 x 254 mm
Gewicht 860 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Medizinische Fachgebiete Gynäkologie / Geburtshilfe
Medizin / Pharmazie Medizinische Fachgebiete Pädiatrie
Studium 1. Studienabschnitt (Vorklinik) Histologie / Embryologie
ISBN-10 1-138-32565-1 / 1138325651
ISBN-13 978-1-138-32565-4 / 9781138325654
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Zytologie, Histologie und mikroskopische Anatomie

von Ulrich Welsch; Wolfgang Kummer; Thomas Deller

Buch | Hardcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 75,60